Article
Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease.
Rheumatology (Oxford, England) - 1 Jun 2001
Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M
Abstract excerpt
OBJECTIVES: To determine whether plasma interleukin-6 (IL-6) and G/C base exchange polymorphism at position -174 of the IL6 gene have an effect on the clinical manifestations of primary Sjögren's syndrome (pSS). METHODS: Levels of circulating IL-6 protein and polymorphism of the IL6 gene were analysed in 66 patients with pSS and in 400 healthy subjects. These data were studied in relation to clinical data on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
